TG Therapeutics | TGTX - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 540M 1000K 2026-03
Ardelyx USD 246.97M 2.62M 2026-03
Arrowhead Research USD 137.39M 1.69M 2025-12
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Curis USD 12.93M 12.87M 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
J&J USD 2.41B 1.74M 2025-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Novartis USD 1.91B 60K 2026-03
Novavax USD 162.58M 106K 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.31M 95K 2025-12
Verastem USD 77.74M 77.74M 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03